The largest database of trusted experimental protocols

4 protocols using anti cd3

1

Isolation and Activation of CD3+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were isolated by using Ficoll Histopaque gradient (GE Health Care Bio-Sciences, Piscataway Township, NJ). CD3+ T cells were isolated by negative selection using untouched human T cell isolation kit (Life technologies, Carlsbad, CA). Purity of CD3+ T cells was confirmed to be above 97% (data not shown). The cells were cultured in RPMI culture media (Corning CellGro, Manassas, VA) with 10% FCS (Gibco, Eugene, OR), 1% Penicillin/Streptomycin, and 1% L-glutamine (all from Corning CellGro) for 3 days either in the presence or absence of plate-bound anti-CD3 (anti TCR ε hybridoma from ATCC, Manassas, VA) and soluble anti-CD28 (BD Biosciences, San Jose, CA) with or without 100 nM rapamycin (Biotica, Cambridge, UK). In some experiments, IL-4 (100 ng/ml) (Peprotech, Rocky Hill, NJ, Catalog # 200-04), IL-17 (10 ng/ml) (eBioscience, San Diego, CA, Catalog# 14-8179), anti-IL-4 (5 µg/ml) (BioLegend, San Diego, CA, Catalog# 500815), or IL-17 (10 µg/ml) (R&D Systems, Minneapolis, MN, Catalog# MAB 317) was added to the culture media.
+ Open protocol
+ Expand
2

Evaluating Autologous T-cell Activation in CMVST Co-cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
After isolating PBMCs to generate CMVSTs, a portion was cryopreserved for subsequent co-cultures. Thawed autologous PBMCs were rested overnight, and then either these non-activated PBMCs or ATCs, generated by plating the PBMCs on anti-CD3 (ATCC) and anti-CD28 (BD Biosciences) coated plates for 4 h, were labeled with CellTrace Violet (3 μM) and mixed with CMVSTs at a 1:1 ratio. After 4 days in media containing IL-2 at 40 IU/ml, co-cultures were stained with antibodies and analyzed by flow cytometry.
+ Open protocol
+ Expand
3

Regulatory T Cell Suppression Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+CD25+ Regulatory T Cell Isolation Kit (Miltenyi Biotec, Auburn, CA) was used to isolate cells. The median purity of isolation procedures was >90%. CD4+CD25− T cells were stained with 1.5μM CFSE (Molecular Probes/Invitrogen, Carlsbad, CA) for 10 min at room temperature. After quenching by FBS, cells were washed with PBS. A total of 5×104 of CD4+CD25+ cells were cultured in triplicate with 5×104 CFSE-labelled autologous CD4+CD25 T cells stimulated with anti-CD3 (1 μg/mL) (ATCC, Rockville, MD) and anti-CD28 Abs (1 μg/mL) (Miltenyi Biotec, Auburn, CA) in AIM V medium supplemented with IL-2 at 150 IU/mL. As negative controls, CFSE-labelled CD4+CD25-cells were stimulated with anti-CD3 (1 μg/mL) and anti-CD28 (1 μg/mL) in the absence of fresh CD4+CD25+ cells. CFSE expression was measured by flow cytometry on day five after stimulation. CFSE data were analyzed using the ModFit software. The percentages of suppression were calculated based on the proliferation index (PI) of responder cells alone compared with the PI of cultures containing responders and Treg. The program determines the percent of cells within each peak, and the sum of all peaks in the control culture is taken as 100% of proliferation and 0% of suppression.
+ Open protocol
+ Expand
4

T Cell Proliferation and Cytokine Production Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A density gradient with Lymphoprep (Axis-Shield) was performed with blood from patients or healthy subjects. Live PBMC obtained were counted with a hemocytometer using the trypan blue assay. 5 × 106 PBMC were stained with CellTrace Violet (CTV, Thermo Fisher Scientific) to track the proliferation of T cells. After that, a maximum of 500,000 cells were placed in a 96-well plate and activated with purified anti-CD3 (1 μg/mL, OKT 3 ATCC) and anti-CD28 (6 μg/mL, GeneTex) for 72 h. When specified PMA/ionomycin (2 μL/mL, stimulation cocktail, eBioscience) was added in the last 6 h of CD3/CD28 stimulation. Cells were cultured in RPMI medium, supplemented with 10% fetal bovine serum (FBS), HEPES, penicillin/streptomycin (Biowest), nonessential amino acids, glutamine (Gibco), ciprofloxacin (Altana), and β-mercaptoethanol (Sigma Aldrich) at 37°C in 5% CO2. To evaluate intracellular cytokine production, the protein transport inhibitor (2 μL/mL, protein inhibitor cocktail, eBioscience) was added 6 h prior to the end of the activation. After incubation, cells were harvested and processed for intracellular staining.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!